construction release_alert

The Scholars Team is working with OIT to resolve some issues with the Scholars search index

cancel

A Phase 1a/1b Study of the pan-KRAS Inhibitor LY4066434 in Participants with KRAS Mutant Solid Tumors (J5Q-OX-JRDA)

Clinical Trial Grant

Duke Scholars

Principal Investigator John Strickler Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Lilly USA, LLC

Start Date

March 18, 2025

End Date

March 31, 2030

Administered By

Duke Cancer Institute

Awarded By

Lilly USA, LLC

Start Date

March 18, 2025

End Date

March 31, 2030